Mohamed Rawy: Clinical Pearls of Clopidogrel
Mohamed Rawy, Hospital Pharmacist at Specialized Medical Center Hospital, shared on LinkedIn:
”Clinical Pearls of Clopidogrel (Plavix®)
- Irreversible P2Y12 inhibitor antithrombotic
- Loading dose of 600mg has a more rapid and peak effect than doses of 300mg and thus it is preferred to be administered before PCI
Patients with Known to be poor CYP2C19 metabolizer will have reduced effect of clopidogrel and should use another P2Y12 inhibitor
- Avoid concomitant administration with PPI except Pantoprazole or Dexlansoprazole or Rabeprazole
Preferred over prasugrel and ticagrelor in patients with HBR or in case of thrombocytopenia
Check algorithm approved by ESC for switching between P2Y12 inhibitors (Do not combine together)
- Has many approved indications like IHD , IS , PAD , TAVI
Alternative to Aspirin in cases of Essential thromcythemia or Kawasaki disease or polycythemia vera
Can be used as a part of TAT for patients with ACS and AF
Duration of DAPT depends on Ischemic and Bleeding risks
Can be used for ACS patients who has thrombocytopenia up to a platelet count of 30.000 cell/mm3
It should be withhold before cardiac surgery by 1-5 days and by 5 days if non cardiac surgery and restart ASAP (≤24 hours) postoperative
- Bleeding can be reversed by administration of Desmopressin
Can be used during pregnancy or breastfeeding if ischemic event occurs
For full information kindly read the monograph (Drugs of ICU)”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 11:53Eduardo Ortiz Bello: The Endothelium in Hemostasis and Microcirculation
-
Nov 16, 2026, 11:51Phil Spinella: Advancing Transfusion Medicine Through Collaboration
-
Nov 16, 2026, 11:46Madiha Chowdhury: Behind the Scenes of Blood Transfusion Services
-
Nov 16, 2026, 11:43Nasir Al Allawi: Honouring Excellence in Haematopathology
-
Nov 16, 2026, 11:39Osman El-Maarri: Delete Two Genes from a Cell Line and It Secretes Twice as much Factor VIII
-
Nov 16, 2026, 11:37Chaza Alaji: Unexplained Bruising-Beyond Platelet Counts and Coagulation Tests
-
Nov 16, 2026, 11:33Obed Asumadu: How Can Advanced Laboratory Diagnostics Improve the Detection and Management of Haemophilia?
-
Nov 16, 2026, 11:29Amman Yousaf: Pulmonary Embolism Mortality in Patients With Coagulation Disorders at AHA 2026
-
Nov 16, 2026, 10:48Tareq Abadl: Why the Kell Blood Group System Matters